The FDA granted 510(k) clearance for the Eagle device, a Q-switched, 532 nm-wavelength, frequency-doubled Nd:YAG glaucoma laser for selective laser trabeculoplasty, according to a press release from Belkin Vision.
The device delivers laser energy in a noncontact procedure through the limbus to the trabecular meshwork without the use of a gonioscopy lens, the release said.
The Eagle device “automatically defines the target location [and] then applies the laser treatment sequence while the eye tracker compensates for any eye movement,” the release said. It also incorporates Direct-SLT